Publikace
- Immuno chemotherapy (anti CD20 and fludarabin/cyclophosphamide) and high dose chemotherapy with ASCT increases molecular remission rate but cannot pretend relapsesPublikace bez příslušnosti k fakultě
- Immuno chemotherapy (Anti CD20 and Fludarabin/Cyclophosphamide) and high dose chemotherapy with ASCT increases molecular remission rate but cannot prevent relapsesPublikace bez příslušnosti k fakultě
- Cell Dysplasia - Cell Dysplastic Features (A Morphological Note)2023 | 1. lékařská fakulta
- The Reduction of the Cell Nuclear Size in the Cell Body Space During the Differentiation Might Be Cell Lineage Specific (A Retrospective Morphological Note)2023 | 1. lékařská fakulta
- Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma in the real world2022 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové, 3. lékařská fakulta, Lékařská fakulta v Plzni
- RNA Concentration and Content in the Nucleoli and Cytoplasmic Rim in Differentiating Lymphocytes of Patients Suffering from B Chronic Lymphocytic Leukaemia - a Cytochemical Note2022 | 1. lékařská fakulta
- CD31/PECAM-1 impacts engraftment, growth and spread of mantle cell lymphoma cells and positively correlates with extramedullary involvement2021 | 1. lékařská fakulta
- The Cell Body Space Occupied by the Nucleus During the Cell Differentiation in Human Lymphocytic, Granulocytic and Erythroid Cell Lineages2021 | 1. lékařská fakulta
- Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab2019 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové, 3. lékařská fakulta
- 18F-FDG PET/CT obraz Erdheimovy-Chesterovy nemoci - přehled českých pacientů2018 | 1. lékařská fakulta
Loading network view...